A component traditional Chinese medicine for treating cardiac insufficiency in coronary heart disease and its preparation method

Abstract

The invention relates to a Chinese medicine composition for treating coronary disease and cardiac insufficiency and a preparation method thereof. The invention provides a Chinese medicine composition for treating chronic heart failure and a preparation method thereof. The composition comprises 10-30 weight portions of radix astragali, 10-20 weight portions of salvia miltiorrhiza, 5-15 weight portions of monkshood, 10-15 weight portions of radix scrophulariae, 10-20 weight portions of honeysuckle flower and 5-15 weight portions of licorice, and prepared by extracting the effective ingredients of the formula with a certain preparation technology, then mixing the ingredients according to the dosages and preparing into the granular formulation. A patient needs to take one packet of the Chinese medicine composition two times per day.

Description

technical field [0001] The invention relates to the field of traditional Chinese medicinal compositions, in particular to a medicinal composition for treating cardiac insufficiency due to coronary heart disease, which is an effective component traditional Chinese medicine with functions of nourishing Qi and Yang, promoting blood circulation and detoxification. Background technique [0002] Cardiac insufficiency (heart failure), which is a change in myocardial structure and function due to initial myocardial injury from any cause (eg, myocardial infarction, cardiomyopathy, hemodynamic overload, inflammation, etc.) that eventually leads to ventricular pumping and / or Low filling function. Clinical pathogenesis and clinical manifestations include symptoms such as dyspnea, weakness, and fluid retention caused by myocardial remodeling. Epidemiological surveys show that the 6-year mortality rate of heart failure patients is as high as 80% for men and 65% for women; the annual mort...

AI Technical Summary

Problems solved by technology

The 2007 Guidelines for the Diagnosis and Treatment of Cardiac Insufficiency Conventional treatment of heart failure includes the combined use of angiotensin-converting enzyme inhibitors (ACEI) / angiotensin II receptor blockers (ARB) and β-blockers to treat cardiac function. Insufficiency, although it can effectively improve the symptoms and signs of patients with heart failure, it is generally difficult to prevent the decline in cardiac function and the continuous development of the disease. and other side effects, and not effective for all patients

The combined application of ARB, ACEI, diuretics, β-receptor blockers, cardiotonic agents, etc. has been shown in theory or in animal and cell experiments to have a certain effect on the prevention and treatment of heart failure, and large-scale clinical trials are still in progress